Oncocross Co. Ltd. (382150) Stock Forecast & Analysis

Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Oncocross Co. Ltd. (382150:KRX), powered by AI.

Current Price
₩4,670
P/E Ratio
-6.4
Market Cap
57.0B
Sector
Technology
What is the Oncocross Co. Ltd. stock price forecast?

Oncocross Co. Ltd. is currently trading at ₩4,670. View real-time AI analysis on Alpha Lenz.

What is Oncocross Co. Ltd. insider trading activity?

View the latest insider trading data for Oncocross Co. Ltd. on Alpha Lenz.

What is Oncocross Co. Ltd.'s P/E ratio?

Oncocross Co. Ltd.'s P/E ratio is -6.4.

Oncocross Co. Ltd.

KRX · 382150
₩4,670-130(-2.71%)Market closedKRX regular session 09:00–15:30 KST
Ask about Oncocross Co. Ltd.'s future dividend policy...
Alpha Chat Insight

Oncocross Co. Ltd. trades at a P/E of -6.4 (undervalued) with modest ROE of -52.8%. 3Y revenue CAGR of 35.1% highlights clear growth momentum.

Ask for details

Company Overview

Oncocross Co. Ltd. is a prominent company operating in the biotechnology sector, with a focus on developing innovative medical and therapeutic solutions. The primary goal of this company is to research and advance treatments that address critical unmet medical needs. Specializing in areas like oncology and other life-threatening diseases, Oncocross Co. Ltd. employs cutting-edge technologies in drug discovery and development. Its role in the market is significant as it contributes to the pipeline of new drugs that may transform patient care and healthcare outcomes. By harnessing breakthroughs in science and technology, Oncocross Co. Ltd. aims to play a crucial role in the global effort to combat complex health challenges. As a player in the biotech industry, it is an important part of the pharmaceutical development ecosystem, potentially influencing the availability and types of new treatments available on the market.

CEO김이랑, 강지훈 (각자대표)
SectorTechnology
IndustrySoftware - Infrastructure
0

Company Statistics

FY 2025

Profile

₩56,955,119,190Market Cap
₩370,460,580Revenue
12.20MShares Out
0Employees

Margins

100.00%Gross
-1949.38%EBITDA
-2383.65%Operating
-2410.17%Pre-Tax
-2410.17%Net

Valuation

-6.38P/E
4.26P/B
153.74EV/Sales
-8.24EV/EBITDA
-5.31P/FCF

Growth (CAGR)

35.10%Rev 3Yr
32.71%Rev 5Yr
N/AOp Inc 3Yr
N/AOp Inc 5Yr
N/ANet Inc 3Yr
N/ANet Inc 5Yr

Returns

-34.67%ROA
-52.79%ROE
-32.63%ROIC

Financial Health

₩2,797,002,190Cash & Cash Equivalents
₩12,787,969,130Net Debt
116.55%Debt/Equity
N/AInterest Cov

Frequently Asked Questions

Oncocross Co. Ltd. (ticker: 382150) is a company listed on KRX in the Technology sector (Software - Infrastructure). Market cap is $57.0B.

The current price is ₩4,670 with a P/E ratio of -6.38x and P/B of 4.26x.

ROE is -52.79% and operating margin is -2383.65%. Annual revenue is $370M.

Alpha Lenz
Singapore
Treasurer Pte Ltd | License: 202346277E
9 Straits View Marina One West Tower #05-07 Singapore 018937
contact@treasurer.co.kr
©2026 Treasurer Pte Ltd. All rights reserved.
Oncocross Co. Ltd. (382150) Stock Forecast 2026 ₩4,670 — Price, Financials & Analyst Targets | Alpha Lenz